Ken Griffin Genenta Science S.P.A. Transaction History

Citadel Advisors LLC

  • $559 Billion
  • Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Genenta Science S.P.A. stock. As of the latest transaction made, Citadel Advisors LLC holds 11,167 shares of GNTA stock, worth $43,997. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,167
Holding current value
$43,997
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$4.08 - $6.92 $45,561 - $77,275
11,167 New
11,167 $48,000

Others Institutions Holding GNTA

# of Institutions
5
Shares Held
360K
Call Options Held
0
Put Options Held
0
View Full List

About Genenta Science S.p.A.

GNTA Quotes by TradingView
  • Ticker GNTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,216,900
  • Market Cap $71.8M
  • Description
  • Genenta Science S.p.A., a clinical-stage biotechnology company, engages in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors in Italy. The company's lead product candidate is Temferon, which is in Phase 1/2a clinical trials for use in the treatment of glioblastoma multiforme in patients with unmethylated...
More about GNTA
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email